---
title: "Gilead Sciences Insider Sold Shares Worth $14,073,241, According to a Recent SEC Filing"
date: "2025-02-14 16:28:52"
summary: "Andrew D Dickinson, Chief Financial Officer, on February 12, 2025, sold 137,676 shares in Gilead Sciences  for $14,073,241. Following the Form 4 filing with the SEC, Dickinson has control over a total of 171,223 common shares of the company, with 171,223 shares held directly. SEC Filing:www.sec.gov/Archives/edgar/data/882095/000112760225004784/xslF345X05/form4.xml"
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Andrew D Dickinson, Chief Financial Officer, on February 12, 2025, sold 137,676 shares in Gilead Sciences for $14,073,241. Following the Form 4 filing with the SEC, Dickinson has control over a total of 171,223 common shares of the company, with 171,223 shares held directly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/882095/000112760225004784/xslF345X05/form4.xml](https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/xslF345X05/form4.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250214:A3317472:0/)
